KONDO Tsunenori
   Department   School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine
   Position   Professor
Article types Original article
Language English
Peer review Peer reviewed
Title The magnitude of best tumor shrinkage during second-line targeted therapy affects progressionfree survival but not overall survival in patients with metastatic renal cell carcinoma.
Journal Formal name:Japanese journal of clinical oncology
Abbreviation:Jpn J Clin Oncol
ISSN code:03682811/14653621
Domestic / ForeginForegin
Volume, Issue, Page 46(6),pp.568-574
Author and coauthor ISHIHARA Hiroki†, KONDO Tsunenori*, OMAE Kenji, TAKAGI Toshio, IIZUKA Junpei, KOBAYASHI Hirohito, TANABE Kazunari
Authorship 2nd author,Corresponding author
Publication date 2016/06
DOI 10.1093/jjco/hyw024